1789 — AK Medical Holdings Income Statement
0.000.00%
Last trade - 00:00
- HK$5.46bn
- HK$4.64bn
- CNY1.05bn
- 76
- 30
- 15
- 30
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 601 | 927 | 1,035 | 761 | 1,052 |
Cost of Revenue | |||||
Gross Profit | 409 | 643 | 715 | 499 | 636 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 429 | 611 | 666 | 662 | 832 |
Operating Profit | 171 | 316 | 369 | 99.4 | 220 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 175 | 321 | 377 | 109 | 240 |
Provision for Income Taxes | |||||
Net Income After Taxes | 145 | 267 | 314 | 92.6 | 205 |
Net Income Before Extraordinary Items | |||||
Net Income | 145 | 267 | 314 | 92.6 | 205 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 145 | 267 | 314 | 92.6 | 205 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.138 | 0.252 | 0.29 | 0.083 | 0.197 |
Dividends per Share |